A&D Pharma: Unaudited Financial Statement for the 12 Months Ended 31 December 2009
InPR 2010, March 22
-
- $5.99
-
- $5.99
Publisher Description
18% year-on-year RON denominated consolidated sales growth3% year-on-year EUR denominated consolidated sales growth87% year-on-year increase in EUR denominated EBITDA166% year-on-year increase in EUR denominated Operating profit BUCHAREST (Romania), Mar 22, 2010 -- (InPR) -- A&D Pharma Holdings N.V. (the C[pounds sterling]GroupC[yen], the C[pounds sterling]CompanyC[yen] or C[pounds sterling]A&D PharmaC[yen]), the Dutch holding company that owns the largest integrated pharmaceutical wholesale, marketing and sales, and retail business in Romania, today announces its unaudited financial statements for the twelve months ended 31 December 2009 prepared in accordance with IFRS.
More Books Like This
A&D Pharma Holdings N.V. Signs Agreement to Acquire Central & Eastern European Private Pharmaceutical Companies
2009
DRUG INDUSTRY
2018
Pharmaceutical Prices in the 21st Century
2014
Covidien Reports Fiscal 2007 Net Sales of $10.2 Billion (Company Overview) (Financial Report)
2008
Is Cost Containment Impacting Pharmaceutical Innovation?
2008
Covidien Reports Net Sales up 10% for Second QTR Fiscal 2011 (Company Overview) (Financial Report)
2011
More Books by InPR
A&D Pharma Holdings N.V. Signs Agreement to Acquire Central & Eastern European Private Pharmaceutical Companies
2009
EFSE Expanding to Four More Countries of the European Eastern Neighbourhood Region
2009
The Koas. Family is Awarded the Prestigious Us-Based Carnegie Medal of Philanthropy in the 40th Year of the Establishment of the Vehbi Koas. Foundation
2009
Krka Presented January to September Operating Results and Future Plans
2009
Specifications About the New Regulated Natural Gas Supply Contracts
2009
Nowadays It is 5 Times More Difficult to Buy an Appartment Than It was 20 Years Ago
2009